Advanced Biomed (ADVB) vs XWELL (XWEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Advanced Biomed is the larger company by market cap ($10.1 million vs $7.9 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADVB | XWEL |
|---|---|---|
| Share price | $6.12 | $0.9189 |
| Market cap | $10.11M | $7.89M |
| 1-day change | -2.86% | +1.87% |
| YTD return | +4.79% | — |
| 1-year return | -34.89% | — |
| P/E ratio (TTM) | 1.26 | — |
| EPS (TTM) | $4.85 | $-5.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.23 | $2.20 |
| 52-week low | $3.61 | $0.26 |
| Distance from 52-week high | -74.74% | -58.23% |
| Average volume | 1.75M | 36.45K |
| Shares outstanding | 1.65M | 8.59M |
| Employees | 31 | 175 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Medical Specialities | Other Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Advanced Biomed in Health Care and XWELL in Consumer Discretionary.
About Advanced Biomed
ADVB stock →Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product.
Health Care · Medical Specialities · 31 employees
About XWELL
XWEL stock →XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.
Consumer Discretionary · Other Consumer Services · 175 employees
ADVB vs XWEL FAQ
Which is bigger, Advanced Biomed or XWELL?
Advanced Biomed (ADVB) is larger, with a market capitalization of $10.11M compared with $7.89M for XWELL (XWEL).
Are Advanced Biomed and XWELL in the same industry?
No. Advanced Biomed is in the Health Care sector, while XWELL is in Consumer Discretionary.